Medical Services

Anaemia of Chronic Kidney Disease (CKD) is a common problem that happens when kidney function grows worse. Erythropoietin is a hormone that the kidneys make that tells the bone marrow to make red blood cells. In CKD, diminished erythropoietin secretion results in decreased red blood cell formation, which causes anaemia. Iron deficiency, long-term inflammation, and shorter red blood cell life also make the situation worse.

Some common signs are tiredness, weakness, disorientation, trouble breathing, and pale complexion. Anaemia in CKD leads to a lower quality of life, problems with thinking, and a higher risk of heart disease and death. Checking haemoglobin levels, iron studies (ferritin, transferrin saturation), and erythropoietin levels is part of the diagnosis.

Treatment aims to resolve problems that can be fixed, like iron deficiencies, and make erythropoiesis-stimulating agents (ESAs) work better to keep haemoglobin levels at the right level. Dialysis patients generally choose intravenous iron supplementation to ensure they have enough iron stored up. Blood transfusions may be necessary in severe or resistant situations.

Recognising and treating anaemia in CKD early leads to better patient outcomes, less disease progression, and better overall health. Regular monitoring and personal treatment are essential elements of optimal management for patients with CKD-related anaemia.